Skip to content

The impact of lung ventilation strategy monitored by EIT on postoperative pulmonary complications after thoracoscope

The impact of lung ventilation strategy monitored by EIT on postoperative pulmonary complications after thoracoscope

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083247
Enrollment
Unknown
Registered
2024-04-19
Start date
2024-05-31
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative complications of thoracoscopic surgery

Interventions

Test group:The day before surgery, EIT was used to measure the ventilation status in supine position, left lateral position, and right lateral position, with a duration of 1 minute each. Within 15 min
Control group:On the day before surgery, EIT was used to measure the ventilation in supine, left lateral, and right lateral positions, with a duration of 1 minute each. Within 15 minutes after anesthe

Sponsors

Tangdu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: a. Sign an informed consent form; b. BMI: 18.5-29.9kg/m2; c. Patients scheduled for surgery under general anesthesia or thoracoscopy; d. Age = 18; e. The postoperative pulmonary complication score is moderate or high risk; f. ASA level I-II; g. No conductive suture, no multiple chest tubes.

Exclusion criteria

Exclusion criteria: a. Preoperative atelectasis and pleural effusion were present, and positive airway pressure ventilation (such as continuous positive airway pressure in sleep obstructive sleep apnea syndrome) was used before surgery; b. Emergency surgery; c. Contraindications for EIT (pacemakers, automatic implantable cardioverter defibrillators, and implantable pumps); d. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Incidence rate of postoperative complications of lung surgery after surgery;

Secondary

MeasureTime frame
The severity of PPCs;Difference in ventilation volume between T0 healthy lung and T2 healthy lung;Length of hospital stay;Does the experimental group experience atelectasis from the end of surgery to the exit of PACU and the time of occurrence;heart rate;Average blood pressure;Cardiac index;Central venous pressure;Cardiac displacement;Partial pressure of carbon dioxide;Oxygen partial pressure;Finger pulse oxygen;Oxygenation index;hemoglobin;lactic acid;PH;Respiratory rate;Tidal volume;Inspiratory peak pressure;End respiratory carbon dioxide;Dynamic lung compliance;Drive pressure;The difference in ventilation volume between T2 healthy and diseased lungs and T4 healthy and diseased lungs, respectively;Intraoperative dosage of vasoactive drugs;

Countries

China

Contacts

Public ContactSun Xude

Tangdu Hospital, Xinsi Road, Baqiao District, Xi'an City, Shaanxi Province

sunxvdes@163.com+86 138 9190 5550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026